1
/
of
1
Elabscience
SKU:PKSH032210
Recombinant Human CD27/TNFRSF7 Protein (Fc & His Tag)
Recombinant Human CD27/TNFRSF7 Protein (Fc & His Tag)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human CD27/TNFRSF7 Protein (FC & HIS TAG), a cutting-edge product meticulously engineered to meet the highest standards of quality and efficacy. This protein, derived from advanced recombinant technology, showcases exceptional purity and functionality, making it an indispensable tool for various research applications.
The Recombinant Human CD27/TNFRSF7 Protein (FC & HIS TAG) boasts a fusion construct comprising the Fc region of human IgG1 and a histidine (His) tag, ensuring enhanced stability and ease of purification. This unique combination empowers researchers with a reliable and versatile protein that can be utilized in a multitude of experimental settings.
With its remarkable affinity for CD27, a member of the tumor necrosis factor receptor superfamily, this protein exhibits unparalleled specificity and binding capacity. This attribute enables precise and accurate investigations into the intricate mechanisms underlying CD27-mediated signaling pathways, immune responses, and cellular interactions.
Furthermore, the Recombinant Human CD27/TNFRSF7 Protein (FC & HIS TAG) offers exceptional bioactivity, enabling researchers to explore its potential therapeutic applications. Its robust and consistent performance guarantees reliable and reproducible results, facilitating groundbreaking discoveries and advancements in the field of immunology and beyond.
In addition to its exceptional quality, this protein is manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. Each vial is meticulously tested to meet the highest industry standards, guaranteeing optimal performance and customer satisfaction.
In summary, the Recombinant Human CD27/TNFRSF7 Protein (FC & HIS TAG) represents a pinnacle of scientific innovation, offering researchers an invaluable tool to unravel the complexities of CD27-mediated processes. With its unrivaled purity, functionality, and reliability, this protein is poised to revolutionize the realm of immunological research and pave the way for groundbreaking discoveries.
The Recombinant Human CD27/TNFRSF7 Protein (FC & HIS TAG) boasts a fusion construct comprising the Fc region of human IgG1 and a histidine (His) tag, ensuring enhanced stability and ease of purification. This unique combination empowers researchers with a reliable and versatile protein that can be utilized in a multitude of experimental settings.
With its remarkable affinity for CD27, a member of the tumor necrosis factor receptor superfamily, this protein exhibits unparalleled specificity and binding capacity. This attribute enables precise and accurate investigations into the intricate mechanisms underlying CD27-mediated signaling pathways, immune responses, and cellular interactions.
Furthermore, the Recombinant Human CD27/TNFRSF7 Protein (FC & HIS TAG) offers exceptional bioactivity, enabling researchers to explore its potential therapeutic applications. Its robust and consistent performance guarantees reliable and reproducible results, facilitating groundbreaking discoveries and advancements in the field of immunology and beyond.
In addition to its exceptional quality, this protein is manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. Each vial is meticulously tested to meet the highest industry standards, guaranteeing optimal performance and customer satisfaction.
In summary, the Recombinant Human CD27/TNFRSF7 Protein (FC & HIS TAG) represents a pinnacle of scientific innovation, offering researchers an invaluable tool to unravel the complexities of CD27-mediated processes. With its unrivaled purity, functionality, and reliability, this protein is poised to revolutionize the realm of immunological research and pave the way for groundbreaking discoveries.
Share
